Update of the estimated consolidated results for the 1st half of 2022

EUROPLASMA: Update of the consolidated results estimated for the 1st half of 2022

23-Sep-2022 / 08:00 CET/CEST
Regulatory information provided by EQS Group.
The content of this press release is the responsibility of the issuer.

Press release – Bordeaux, September 23, 2022

Update on estimated consolidated results

of 1Ahem semester 2022

Europlasma, specialist in the treatment of hazardous waste, recovery of materials and decarbonisation, announcement, following Press release of August 4 and as for the consolidation work, which :

  • the Group’s estimated operating profit for 1Ahem semester 2022 comes out positive[1] at €88K

  • net profit attributed to the group is estimated at -2.4 million euros, 8.7 million euros higher than the same period of the previous year.

The consolidated annual accounts will be approved by the Board of Directors scheduled for October 25, 2022 and will be communicated in accordance with current regulations.[2].

In addition, the semi-annual report that includes the consolidated semi-annual financial statements and an activity report related to these semi-annual financial statements will be available no later than October 31, 2022.[3].


This press release contains forward-looking information and statements relating to Europlasma and its activities. Europlasma believes that this information and forward-looking statements are based on reasonable assumptions as of the date of publication. However, the fulfillment of the forecasts expressed in this press release cannot be guaranteed, which are subject to risk factors, including those described in chapter 2 of the Annual Financial Report for the year ended December 31, 2021 available on the website europlasma.com in the “regulated information” section as well as in its annual management reports and press releases (documents available on the website europlasma.com). Forward-looking information and statements contained in this press release are also subject to risks unknown to Europlasma or not considered material by Europlasma as of this date. Therefore, the future performance of Europlasma may differ materially from the information and forward-looking statements provided and Europlasma does not undertake to supplement, update or modify such information and forward-looking statements due to new information, a future event or for any other reason. This press release and the information it contains do not constitute an offer or solicitation for the sale or purchase of securities issued by the Company. Europlasma makes available to the public on its website a FAQ dedicated to anyone who wishes to obtain information on the financial securities issued by Europlasma.


Europlasma is a French group expert in decontamination, whose know-how for 30 years has been based on its own technology, the plasma torch, which allows extremely high temperatures to be obtained. Europlasma’s activity consists of designing and developing the multiple applications of the plasma torch, at the service of man and his environment. Its innovative solutions are intended for the treatment and recovery of hazardous waste and gases, as well as applications for industries concerned with reducing their environmental footprint. At the same time, Europlasma has deployed an RSE (Solid Recovered Fuels) preparation activity, based on its unique know-how developed at its Morcenx site. EUROPLASMA’s share is listed on Euronext GROWTH™, (FR0013514114-ALEUP / LEI 969500WYVNHBV1ABQ250). For more information : europlasma.com.



Shareholder Relationscontactbourse@europlasma.com

NEWS finance and communication

Amaury DUGAST – Press relations

+ 33 (0) 153 673 674 – adugast@actus.fr

Anne-Catherine HELLO – Investor Relations

+ 33 (0) 153 673 693 – europlasma@actus.fr

[1] Includes the capital gain from the acquisition of the Satma business for an amount of 7 million euros net (deduction made from the absorbed liabilities)

[2] The semi-annual accounts are not audited by the account auditors (Euronext Growth)

[3] Euronext Growth Market Rules (§ 4.2.1)

Regulatory Filing PDF File

Document : Update of the estimated consolidated results for the 1st half of 2022

Leave a Comment

Your email address will not be published. Required fields are marked *